Introduction: Unwarranted clinical variation (UCV) can be described as variation
possible that health care professionals and services are not consistently adhering to evidence-based guidelines. Identifying services and practices where variation is common is therefore critical.
Reducing UCV is identified as a priority of several health systems internationally. [5] [6] [7] In New South Wales, Australia, the ACI have established a taskforce focusing on reducing UCV but determined that confusion amongst health service providers and consumers regarding how best to identify and interpret UCV is a barrier to progress. 8 For example, country-level data present rates of variation, but there is a lack of clarity regarding how these rates should be interpreted. 9 Without UCV guidelines for policy makers, managers, and clinicians that are easy to access and apply, systematic approaches to reducing UCV cannot be implemented. To assist policy-makers to start to address this issue, a rapid review was commissioned by the ACI to address the following questions:
1. How do conceptual or theoretical frameworks currently attempt to define UCV?
2. What approaches or strategies have been used to (1) identify/ determine variation as UCV and/or (2) address UCV?
3. What evidence is there of the effectiveness of the approaches identified in addressing UCV?
| METHODS
This literature review utilized a rapid evidence assessment (REA) methodology. This research methodology uses the same methods and principles as a systematic review but makes concessions to the breadth or depth of the process to address key issues about the topic under investigation. [15, 64, 65 ] An REA provides a balanced assessment of what is already known about a problem or issue, and the strength of evidence. The lower cost, relative to full systematic reviews, makes REAs helpful for informing health care decision makers. 10 In the present review, REA was used in order to provide a focused review to address policy questions. The search was therefore limited to contemporary literature (post 2006) identified from 2 major electronic databases and grey literature that explicitly used the term "unwarranted clinical variation". A rapid review of UCV amongst paediatric populations was published in 2016; we sought to complement and build on this existing review by studying only adult studies.
[66]
The REA was structured using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-PRISMA statement. • Types of settings: Public or private hospitals, day procedure centres, general practice, or other primary/community care facilities that included an adult population (18 years plus).
• Types of study design: Conceptual, theoretical, quantitative, or qualitative studies of any research design.
• Outcomes:
• Conceptual or theoretical frameworks used to identify and/or understand warranted or unwarranted clinical variation in relation to any health care outcome AND/OR
• Data regarding the identification and/or assessment of unwarranted clinical variation in relation to any health care outcome.
• Given the plethora of studies on clinical care variation and the lack of consensus in definition, only studies explicitly using the term "unwarranted clinical variation" were eligible for inclusion.
| Exclusion criteria
Non-empirical literature such as opinion pieces, letters, and editorials and studies that employed hypothetical vignettes were excluded.
| STUDY IDENTIFICATION

| Electronic databases
A range of text words, synonyms, and subject headings were developed for the 3 review questions of unwarranted clinical variation, standards (and deviation from these), and health care environment. These text words, synonyms, and subject headings were used in searching 2 electronic databases that index journals of particular relevance to the review topic (Medline and PubMed) from January 2006 to April 2017. Two slightly different strategies were employed to address research question one (see supplementary file 1) and research questions 2 and 3 (see supplementary file 2). Hand searching of reference lists of published papers ensured that relevant published material was captured. Results were merged using reference-management software (Endnote, version X8) and duplicates removed.
| Grey material
Qualitative studies reported in the grey literature (eg, reports and papers published by government departments, intragovernmental agencies, public or private health service providers, non-government agencies, consumer organizations, professional bodies, advocacy groups) were identified by searching the websites of relevant organizations (see supplementary file 3 for a list of the relevant organizations included). Literature identified was assessed along with the papers from the database searches.
| STUDY SELECTION AND DATA EXTRACTION
Three reviewers (S.M., R.A.H., R.H.) independently screened the titles and abstracts (or executive summaries for grey literature). Copies of the full articles were obtained for those that were potentially relevant.
Inclusion criteria were independently applied to the full text articles by each of the reviewer team (all authors). Disagreements were resolved through final discussion between 2 members of the review team (R.H., E.M.). The following data were extracted from eligible literature:
author(s), publication year, sample, setting, objective, framework used, and main findings.
| DATA SYNTHESIS
Findings were analysed using a narrative empirical synthesis in stages, based on the review questions. 12 A quantitative analytic approach was not appropriate due to the heterogeneity of study designs, contexts, and types of literature included. Initial descriptions of the eligible studies and results were tabulated (Tables 1 and 2 ). Patterns in the data were explored to identify consistent findings. Interrogation of the findings explored relationships between study characteristics and their findings; the findings of different studies; and the influence of different outcome measures, methods, and settings on the resulting data.
7 | RESULTS
| Results of the search
After removing duplications, 2093 records were identified. Title and abstract screening review resulted in 249 references that fulfilled the inclusion criteria, for which full text of the publications was obtained. A total of 49 publications were included in the review based on the inclusion and exclusion criteria; 21 articles were identified as eligible from database full text review; 24 studies were identified from the grey literature and 4 further studies were identified via handsearching. Figure 1 shows the selection process.
| Excluded studies
Studies were largely excluded from the database search due to lack of explicit UCV focus (n = 2074). Many of these studies sought to identify and present different types of clinical variation in specific populations, conditions or practices but presented this with no discussion of what was considered "unwarranted", undesirable or inappropriate variation. These 3 terms were used interchangeably in the literature.
These studies did not therefore address the review questions. Further exclusions (19) were due to publication type, eg, editorial pieces that did not present conceptual or theoretical frameworks. assesses utilization rates of a particular practice to determine whether utilization is at an "acceptable" level based on average utilization rates.
A determination is made as to whether any given practice is being undertaken at a statistically significant rate outside of the defined parameters. 13 The variation-attribute indicates whether differences observed across environments can be considered "unwarranted"
based on statistical analysis. The Atlas draws upon the uncertainty hypothesis to set the statistical parameters and therefore determines whether variation in practice is unwarranted.
13
A third theoretical paper reports the use of complexity theory- Goodman Model focuses on paediatric care, and therefore the original paper was excluded from this review of UCV in adult populations. 19 As None stated-statistical analysis used to demonstrate variation within and between surgeons, patients and specialties and the contribution of each to variation in cost.
Database
Gauld, R 2011 USA To assess whether hospitals consider UCV as a problem, the areas in which UCV is of greatest concern and the strategies used to counter UCV. Five high-performing hospitals explored via 39 interviews with managers and clinical staff forming case studies.
307 chief quality officers from acute hospitals in 4 US states surveyed. Case studies using interviews and crosssectional survey. Case study sites identified by those areas considered as high-utilization in the Dartmouth study, survey items regarding possible UCV prevention strategies derived from development by "expert" panel.
Graverholt, B 2013 Norway To (1) quantify overall and diagnosis specific variation in acute hospital admission rates amongst nursing homes and (2) Retrospective analysis of admission data for nursing homes.
None stated-statistical analysis to determine the contribution of each factor to variation. Mercuri and colleagues indicate that the model may apply beyond paediatric care; it is described here. The Goodman Model suggests that UCV is associated with differences in medical resources, utilization, and outcomes that are associated with differences in health system performance. 2 In this model, UCV is explained by the quality, appropriateness, and efficiency of health care. Operationalisation of these concepts is not clearly defined.
2
The Bojakowski Model is a position piece proposing that the degree to which variation is "unwarranted" or "acceptable" is a matter of judgement and cannot be explained by patient needs, local conditions, or the broader health care environment. 2, 20 An absolute measure of whether variation is warranted or not is hard to establish because of complexity in health care delivery, population health needs, and the multitude of factors that combine to create variation. 20 Rather than defining parameters that highlight UCV during evaluation, Bojakowski suggests that combining various sources of information and contextualizing data are critical to establishing the extent to which variation is unwarranted. 14 The grey literature search yielded 9 documents that discussed conceptual or theoretical frameworks for understanding UCV.
21-29
Four of these discussed atlases of variation in Spain, Australia, and the UK National Health Service. [22] [23] [24] 27 The first of the studies reports on the Atlas of Medical Practice Variation in Spain. 23 In the second, a presentation of the NHS Atlas of Variation depicts the guiding principles of clinical community leadership, widespread engagement, co-production with communities, consistent presentation and messaging, and extended reach to NHS decision-makers. 24 Findings indicate substantial regional variations are impacted by the introduction of multi-disciplinary teams, but variations are not explicitly identified as unwarranted; the authors note the challenge in defining problematic variation. 24 The final 2 studies explore how to identify UCV based on the The Wennberg and Goodman frameworks are described earlier. The
European Collaboration for Health Optimisation was a European
Union funded initiative between 2010 and 2014 that sought to identify approaches to address UCV in the EU. 29 The project combined patient-level data from Austria, Denmark, England, Portugal, Slovenia, and Spain to compare and map UCV within and between countries by exploring the number of observed hospital admissions versus the number expected for the given population. 29 The approach focused on "effective care" procedures only in order to identify UCV; it is unclear how the approach could be utilized to identify UCV in areas where the evidence is less clear regarding the optimum treatment.
The report highlights the value of international benchmarking for identifying variation in particular procedures and for providing a larger pool for statistical comparisons but is less informative regarding circumstances in which evidence is less clear regarding optimum treatment. Two groups of studies reported approaches to determine UCV, with suggestions to address UCV. The first group of 4 studies applied a framework to determine UCV in population or hospital level data. 13, [30] [31] [32] The second group of 14 studies applied statistical models, most commonly regression analyses, to identify variation that was considered to be deviating at a statistically significant level from standard, appropriate or expected levels of variability. area so patient-level data must be scrutinized. Substantial unexplained variation in endarterectomy was noted, with authors suggesting extensive distance to specialized services and variation in adoption of carotid stenting. 13 High systematic variation was noted in low-value care, with some exceptions. The authors indicate the 2 likely drivers of variation to be different styles of practice and different adoption of more cost-effective alternatives.
13
A mixed-methods study using surveys and interviews across case study sites explored the degree to which UCV was a concern, and perceptions of the factors leading to such variations. 30 Survey data indicated that UCV was a concern for 90% of the survey respondents who worked in hospital management at a range of levels or quality and safety departments (n = 220), with impact on hospital readmissions as the largest concern. 30 Many of the respondents (75%) reported using strategies in their hospitals to address UCV described below.
The final study utilized the Theoretical Domains Framework, widely used in determining health behaviours, to qualitatively identify factors perceived to influence practice. The Theoretical Domains
Framework was used to explore factors thought to influence deviation from evidence-based recommendations via interviews based on 12 theoretical domains rather than being used as a framework to understand UCV. 32 Findings suggest that deviation from evidence-based guidelines in the assessment of patients with mild traumatic brain injury was largely driven by beliefs about the impact on patient outcomes of using assessment or clinical-decision tools, lack of skills and knowledge in the use of the tools, and lack of social norms in the specialty around the use of such tools. 32 Environmental pressures relating to high patient throughput were also influential in decisionmaking about adherence to evidence-based practice guidelines. 32 The CareTrack study of appropriateness of health care delivery in 52 The presentation discusses approaches to understanding variation using these tools but lacks specific guidance regarding the identification of variation that is Studies largely focused on identifying and defining UCV rather than addressing it. However, approaches for addressing UCV were identified in 4 articles, often in relation to specific conditions. 16, 30, 55, 56 These studies did not necessarily attempt to provide evidence that approaches were effective. Menon and colleagues explored colorectal cancer against Wennberg's framework, exploring instances of effective, preference-sensitive, and supply-sensitive care. 16 The authors highlight the variations in effective care and suggest that investigation of the colorectal cancer care pathway may help to distinguish the points at which unwarranted variations are generated to enable focused interventions. 16 For those variations related to patient preference, Menon and colleagues suggest that UCV often arises when patients are unable to make informed decisions regarding "preferences." Reduced UCV for these types of treatments may be achieved by clinical consultations that focus on relevant treatment options, set realistic expectations, and clearly define patients' outcome goals. 16 A number of precursors to UCV are also identified including lack of multi-disciplinary team (MDT) review, suboptimal clinical data, complex disease, variable attendance by MDT team, and insufficient time in MDT review. 16 A second study explored an intervention to challenge UCV in the treatment of chronic non-cancer pain. 55 The intervention aims to address UCV indirectly through patient education regarding explanatory models for pain and the range of treatment options available. 55 Whilst not explicitly identified by the authors, the intervention focuses on variation that is preference sensitive. The study tracked YouTube views and dissemination of the videos but not impacts on practice.
In a third study, Gauld and colleagues reported a range of strategies identified through interviews with hospital leaders and quality managers to address UCV in acute hospitals. 30 Strategies cited were the use of benchmarking, clinical practice guidelines, blinded report cards, opinion leader education, pay for performance, unblinded report cards, and patient engagement. 30 An example of 1 such strategy was the withholding of performance bonuses for physicians who exceed targets for referred services. The final study is described below (pg. 20) as the focus was on determining the effectiveness of strategies to address UCV in surgery. 56 Three further articles discussed addressing UCV in the grey literature., 7, 21 [62] An OECD press release suggests that UCV should be tackled by governments via public reporting and target setting, policies targeting providers, and patient-centred approaches using tools for shared decision-making. 21 The National Healthcare Quality The report does not discuss specific approaches used during the time period to address UCV or make links to particular strategies and the figure presented.
The most substantial progress in attempting to address UCV was identified in the Getting it Right First Time initiative within the NHS. potential to reduce UCV and associated costs, this is subject not only to clinician engagement but also managerial engagement and action which may be greater in some Trusts and hospitals than others. Whilst some studies identified strategies to address UCV, only 1 study explored the perceived effectiveness of these via surveys of hospital managers. 30 Of the 7 strategies identified to address UCV described earlier in Section 3, the use of benchmarking and clinical practice guidelines were the most common (used by 66% of respondents) and perceived to be "somewhat effective" by 72% of respondents. Yet, the strategy of patient engagement perceived to be "very effective" by the most respondents (41%) was the least utilized; only used in 18% of cases. 30 One further study was identified via hand-searching that provided a literature review of the effectiveness of strategies to reduce UCV in surgery. 56 The authors highlight the challenge of defining UCV, resulting in a focus on those interventions that had an impact on the rates of surgery in any given context. Forty-one studies were included-grouped into 2 categories of interventions to reduce UCV.
The first category was interventions aimed at the decision-pathway, including the development of new evidence of optimum care, the update and dissemination of evidence amongst clinicians, shared decision-making, and the effect of evidence on the provision of surgery for certain disorders. 56 This group of studies demonstrated that evidence of optimum care is essential to identify UCV, but even when such evidence exists, acceptance of new evidence can be slow. Interventions to disseminate best evidence and improve adherence were scarce and demonstrated only very small improvements. 56 Shared decision-making has been consistently identified as the key to reducing UCV in preference-sensitive care categories, with the included studies demonstrating shared decision-making interventions reduced surgery rates for certain conditions such as kneereplacement and prostatectomy in benign cases. 56 Despite shared decision-making, there was no direct evidence demonstrating a resulting reduction in UCV. 56 The second category of interventions included those aimed at health care organizations. Interventions included financial and nonfinancial incentives and direct regulatory and planning approaches. 56 The use and impact of financial incentives were dependent on the health system structure, with differences noted between fully nationalized and free market systems. The latter, largely being influenced by insurers; health care utilization was substantially higher in systems in which individuals mostly obtain at least basic health insurance. 56 Again, the link to UCV is indirect. Non-financial incentives were also identified, with potential for powerful but also unintended undesirable effects. Strategies such as providing increased logistical support were found to be effective in encouraging staff to relocate to areas of need, but not to directly impact UCV. Potential unintended consequences on patient selection were noted as specialists may be reluctant to take on older or less healthy patients. 56 Regulatory approaches include regulation of the number of specialists available in a given area. One such approach is restricting the number of places on a training programme, but this was not associated with reduced activity as it takes some years to filter through to practice. 56 
| DISCUSSION
The review identified 49 publications presenting conceptual, theoretical, or original research regarding the identification of UCV and/or approaches to address the challenge. The search process highlighted a plethora of work exploring types and frequencies of clinical variation internationally; several hundred such studies were identified. Notably, within the evidence base regarding clinical variation, there was a lack of distinction between variation that is warranted or unwarranted, with an implicit suggestion that all variation is problematic. The present review explored what is known to date regarding approaches to identify and/or address UCV from articles that specifically used the term "unwarranted clinical variation." We explore the implications of these findings for policy makers seeking to reduce UCV.
Whilst a heterogeneous group of articles were identified, the body of evidence demonstrates 3 key findings in relation to current work around UCV. Firstly, there is a growing body of sophisticated data regarding the clinical variation arising in various health systems internationally and increasingly rigorous data collection approaches evidenced in the atlases of clinical variation. 6, 13 Secondly, a range of statistical approaches can be applied to this data to determine care that is considered to be outside of any given parameters. Finally, when synthesized, this collection of studies highlights the challenge of determining the parameters for UCV beyond the category of treatments or procedures that are considered to be "effective care"; that is, those agreed to be the optimum care for all patients.
The dominant classification systems relating to variation converge on the notion that optimum care in relation to many treatments and procedures is likely to vary dependent on a range of patient and contextual factors. 17, 23 In many cases, there may not be a single optimal approach from which deviation can be identified and labelled as unwarranted. As such, it is difficult to develop a systematic approach to the operationalisation of frameworks used for categorizing types of variation (such as Wennberg's) in order to identify and address instances in which UCV may be deemed problematic. Work undertaken to date does not provide any conclusive detail regarding how to ascertain what is and is not unwarranted.
The body of evidence demonstrates a substantial and continuing gap in the field of research. Without an understanding of the parameters that distinguish "warranted" and "unwarranted" variation, or the knowledge of if these can in fact be delineated for some procedures or care processes, progress cannot be made to take action in reducing problematic care variation using the approaches identified. Related to the challenge of defining the variation that is unwarranted is the lim-
ited evidence regarding what can and should be done to address UCV, and whether any proposed approaches are in fact, effective.
Without clear operationalisation of frameworks to categorize UCV, assessing the impact of interventions or initiatives to address UCV is also challenging.
2
In attempting to address UCV in New South Wales, the ACI consider UCV as "variation that cannot be explained by the condition or the preference of the patient; it is variation that can only be explained by differences in health system performance." 8 The definition reflects that of the Goodman Model in conceptualizing UCV in the context of health systems performance. 19 Yet this definition is also grounded in the notion of a best practice or optimal approach for every patient and condition, and as such aligns with aspects of the Wennberg model, particularly in relation to the effective care category. The principle of deviation from optimal or "effective" care underpins most of the conceptual frameworks identified here; they are predominantly distinguished by the way in which deviation is conceptualized. It appears that existing models converge on this principle in the absence of data to support an alternative standpoint; Bojakowski is the only model to present a substantially different perspective. 14 
| IMPLICATIONS
The review findings have multiple implications for policy and practice regarding UCV. To date, work has focused on identifying variation and classifying this as potentially unwarranted and currently perpetuates the perception that any clinical variation is problematic. There are multiple competing factors that lead to variation, and these are also apparent in cases that appear to be UCV. Simply identifying possible UCV is insufficient to reduce problematic variation. The identification of potential cases of UCV should be a trigger to explore an aspect of the system or a care pathway, rather than being immediately assumed to be problematic.
In the context of the evidence outlined, it is unsurprising that few studies have developed and evaluated strategies to address UCV and, as such, demonstrated their effectiveness. One approach may be to establish agreed parameters for determining the point at which variation should be investigated for each condition/procedure or treatment within a health system in order to account for a wider range of potentially appropriate care options for many conditions. A decision tool may then support health care services to explore aspects of care in which likely UCV has been detected, to direct action where needed. 
